Gritstone Oncology, Inc.
(NASDAQ : GRTS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.23%42.020.9%$966.08m
JNJJohnson & Johnson
0.25%139.190.7%$783.13m
MRKMerck & Co., Inc.
0.53%81.450.6%$770.77m
BMYBristol-Myers Squibb Company
-0.72%46.961.4%$641.05m
LLYEli Lilly and Company
0.17%117.011.0%$488.90m
ABBVAbbVie, Inc.
-1.37%80.042.2%$419.50m
AZNAstraZeneca PLC Sponsored ADR
1.26%39.151.3%$193.95m
NVSNovartis AG Sponsored ADR
4.03%87.840.2%$171.88m
GSKGlaxoSmithKline plc Sponsored ADR
0.55%40.210.2%$99.12m
NVONovo Nordisk A/S Sponsored ADR Class B
0.56%48.650.1%$66.80m
SNYSanofi Sponsored ADR
1.01%42.540.2%$48.58m
LCILannett Company, Inc.
-5.42%5.7636.7%$9.41m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.71%2.301.6%$0.47m
EPIXESSA Pharma Inc
12.76%2.310.1%$0.01m

Company Profile

Gritstone Oncology, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded in August 2015 by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria and is headquartered in Emeryville, CA.